Singapore has long been one of Asia’s most forward-thinking innovation hubs, and its MedTech sector is a compelling reflection of that reputation. What was once primarily a regional manufacturing base has evolved into a globally recognised centre for medical technology research, development, and commercialisation, and the numbers back it up. With nearly 190 MedTech startups now operating in the city-state and the number of biotech companies in the sector having quadrupled over the past decade, Singapore’s position on the global MedTech map has never been stronger.
How Many MedTech Startups Are There in Singapore?
There are between 176 and 186 MedTech startups in Singapore as of January 2026. There are roughly 72 to 75 funded firms in this quickly expanding industry, of which 24 have obtained Series A+ funding.
Is Singapore’s MedTech Scene Growing?
Yes, Singapore’s MedTech industry is expanding quickly, changing from a hub for regional manufacturing to a worldwide hub for innovation, R&D, and commercialisation. Over the past ten years, the number of biotechnology companies in the industry has increased fourfold.
More from Startups
- Founder Of The Week: Rico Van Der Veen
- Meet The Startups Crowdfunding w/c 09.03.2026
- Top 8 IoT Startups In Germany
- Startup of the Week: Corpora.ai
- Top Blockchain Startups in Denmark
- Hatu Sheikh: Web3 Entrepreneur And Pioneer
- Top Sustainability Startups In Singapore
- International Women’s Day 2026: Tech And Startups By Women Who Are Addressing Women’s Issues, Pt 1
Top MedTech Startups in Singapore to Keep an Eye on
With the MedTech scene growing in Singapore, more and more startups are popping up. Here are the top MedTech startups in Singapore to keep an eye on:
1. NousQ
The first portable robotic device with sensors in the world for treating Otitis Media with Effusion (OME) is NousQ’s CLiKX. It is the primary cause of a child’s hearing loss, medical visits, antibiotic use, and general anaesthesia (GA). If left untreated, there are delays in speech, language, and learning, brain infections, fewer opportunities for employment and social interaction, and a significant carer burden.
2. Aevice Health
The goal of MedTech startup Aevice Health is to transform the treatment of long-term respiratory conditions. The firm creates wearable, AI-powered, non-invasive gadgets that allow for real-time health surveillance for both adults and children by enabling early diagnosis of cardiopulmonary disorders.
3. Tikva Allocell
The goal of the preclinical biotech startup Tikva Allocell is to create “off-the-shelf” T cell treatments for solid tumours. Tikva Allocell seeks to provide safe, efficient, and reasonably priced cancer treatments using its own, IP-protected technology based on allogeneic Epstein-Barr Virus-Specific T cells (ALLO EBVST).
4. Lucence
Precision oncology firm Lucence Diagnostics is situated in Singapore. With an emphasis on early cancer identification and individualised therapy, Lucence specialises in liquid biopsies and molecular diagnostics. Its exclusive technologies make it possible to create non-invasive blood-based tests to find biomarkers and genetic abnormalities unique to cancer.
5. Qritive
Qritive is a cutting-edge artificial intelligence (AI) service provider that is using AI-based solutions to improve health outcomes and advance digital pathology for cancer diagnosis. Qritive builds on deep learning technology to help medical imaging specialists with limited time and resources interpret pathology findings, facilitating quicker diagnosis and shorter treatment times for patients.
